ACM RESEARCH INC-CLASS A (ACMR)

US00108J1097 - Common Stock

14.91  -0.3 (-1.97%)

After market: 14.91 0 (0%)

Fundamental Rating

5

Taking everything into account, ACMR scores 5 out of 10 in our fundamental rating. ACMR was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. ACMR has a medium profitability rating, but doesn't score so well on its financial health evaluation. ACMR has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!



6

1. Profitability

1.1 Basic Checks

In the past year ACMR was profitable.
ACMR had a positive operating cash flow in the past year.
ACMR had positive earnings in each of the past 5 years.
ACMR had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of ACMR (5.03%) is better than 64.81% of its industry peers.
The Return On Equity of ACMR (10.16%) is better than 67.59% of its industry peers.
ACMR has a better Return On Invested Capital (8.48%) than 76.85% of its industry peers.
ACMR had an Average Return On Invested Capital over the past 3 years of 5.41%. This is significantly below the industry average of 11.13%.
The last Return On Invested Capital (8.48%) for ACMR is above the 3 year average (5.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.03%
ROE 10.16%
ROIC 8.48%
ROA(3y)3.99%
ROA(5y)5.23%
ROE(3y)7.16%
ROE(5y)10.85%
ROIC(3y)5.41%
ROIC(5y)6.12%

1.3 Margins

ACMR has a better Profit Margin (12.38%) than 66.67% of its industry peers.
ACMR's Profit Margin has improved in the last couple of years.
The Operating Margin of ACMR (17.89%) is better than 73.15% of its industry peers.
In the last couple of years the Operating Margin of ACMR has grown nicely.
ACMR has a better Gross Margin (49.36%) than 63.89% of its industry peers.
In the last couple of years the Gross Margin of ACMR has remained more or less at the same level.
Industry RankSector Rank
OM 17.89%
PM (TTM) 12.38%
GM 49.36%
OM growth 3Y7.77%
OM growth 5Y14.55%
PM growth 3Y4.93%
PM growth 5Y9.41%
GM growth 3Y3.67%
GM growth 5Y1.44%

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACMR is destroying value.
ACMR has more shares outstanding than it did 1 year ago.
ACMR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACMR has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.03 indicates that ACMR is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.03, ACMR is doing worse than 63.89% of the companies in the same industry.
ACMR has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
ACMR has a Debt to Equity ratio of 0.16. This is comparable to the rest of the industry: ACMR outperforms 47.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 2.03
ROIC/WACC0.59
WACC14.36%

2.3 Liquidity

A Current Ratio of 2.37 indicates that ACMR has no problem at all paying its short term obligations.
The Current ratio of ACMR (2.37) is worse than 61.11% of its industry peers.
A Quick Ratio of 1.34 indicates that ACMR should not have too much problems paying its short term obligations.
ACMR has a worse Quick ratio (1.34) than 76.85% of its industry peers.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 1.34

8

3. Growth

3.1 Past

ACMR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.24%, which is quite impressive.
Measured over the past years, ACMR shows a very strong growth in Earnings Per Share. The EPS has been growing by 55.38% on average per year.
The Revenue has grown by 46.98% in the past year. This is a very strong growth!
The Revenue has been growing by 49.53% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)53.24%
EPS 3Y63.93%
EPS 5Y55.38%
EPS Q2Q%10.53%
Revenue 1Y (TTM)46.98%
Revenue growth 3Y52.71%
Revenue growth 5Y49.53%
Sales Q2Q%21%

3.2 Future

ACMR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.94% yearly.
The Revenue is expected to grow by 22.83% on average over the next years. This is a very strong growth
EPS Next Y26.72%
EPS Next 2Y10.46%
EPS Next 3Y5.94%
EPS Next 5YN/A
Revenue Next Year38.03%
Revenue Next 2Y29.46%
Revenue Next 3Y23.48%
Revenue Next 5Y22.83%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.00, the valuation of ACMR can be described as very cheap.
Based on the Price/Earnings ratio, ACMR is valued cheaply inside the industry as 99.07% of the companies are valued more expensively.
ACMR is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 7.50 indicates a rather cheap valuation of ACMR.
Based on the Price/Forward Earnings ratio, ACMR is valued cheaper than 98.15% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ACMR to the average of the S&P500 Index (23.73), we can say ACMR is valued rather cheaply.
Industry RankSector Rank
PE 7
Fwd PE 7.5

4.2 Price Multiples

96.30% of the companies in the same industry are more expensive than ACMR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.7

4.3 Compensation for Growth

ACMR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ACMR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.26
PEG (5Y)0.13
EPS Next 2Y10.46%
EPS Next 3Y5.94%

0

5. Dividend

5.1 Amount

ACMR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACM RESEARCH INC-CLASS A

NASDAQ:ACMR (12/20/2024, 8:00:00 PM)

After market: 14.91 0 (0%)

14.91

-0.3 (-1.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners60.73%
Inst Owner Change-2.18%
Ins Owners5.19%
Ins Owner Change-30.08%
Market Cap933.81M
Analysts83.08
Price Target32.35 (116.97%)
Short Float %8.03%
Short Ratio2.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)59.94%
Min EPS beat(2)54.06%
Max EPS beat(2)65.81%
EPS beat(4)4
Avg EPS beat(4)80.04%
Min EPS beat(4)54.06%
Max EPS beat(4)145.1%
EPS beat(8)8
Avg EPS beat(8)1389.47%
EPS beat(12)11
Avg EPS beat(12)944.83%
EPS beat(16)14
Avg EPS beat(16)713.69%
Revenue beat(2)2
Avg Revenue beat(2)13.18%
Min Revenue beat(2)4.6%
Max Revenue beat(2)21.75%
Revenue beat(4)4
Avg Revenue beat(4)9.73%
Min Revenue beat(4)0.69%
Max Revenue beat(4)21.75%
Revenue beat(8)7
Avg Revenue beat(8)8.7%
Revenue beat(12)10
Avg Revenue beat(12)9.3%
Revenue beat(16)12
Avg Revenue beat(16)7.08%
PT rev (1m)-3.48%
PT rev (3m)-8.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.43%
EPS NY rev (1m)6.93%
EPS NY rev (3m)13.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.78%
Revenue NY rev (1m)0.97%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE 7
Fwd PE 7.5
P/S 1.28
P/FCF N/A
P/OCF 30.47
P/B 1.05
P/tB 1.05
EV/EBITDA 4.7
EPS(TTM)2.13
EY14.29%
EPS(NY)1.99
Fwd EY13.34%
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)0.49
OCFY3.28%
SpS11.64
BVpS14.18
TBVpS14.14
PEG (NY)0.26
PEG (5Y)0.13
Profitability
Industry RankSector Rank
ROA 5.03%
ROE 10.16%
ROCE 11.01%
ROIC 8.48%
ROICexc 12.24%
ROICexgc 12.28%
OM 17.89%
PM (TTM) 12.38%
GM 49.36%
FCFM N/A
ROA(3y)3.99%
ROA(5y)5.23%
ROE(3y)7.16%
ROE(5y)10.85%
ROIC(3y)5.41%
ROIC(5y)6.12%
ROICexc(3y)10.11%
ROICexc(5y)10.49%
ROICexgc(3y)10.14%
ROICexgc(5y)10.52%
ROCE(3y)7.09%
ROCE(5y)8.23%
ROICexcg growth 3Y-0.21%
ROICexcg growth 5Y-4.84%
ROICexc growth 3Y-0.2%
ROICexc growth 5Y-4.76%
OM growth 3Y7.77%
OM growth 5Y14.55%
PM growth 3Y4.93%
PM growth 5Y9.41%
GM growth 3Y3.67%
GM growth 5Y1.44%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 1
Cap/Depr 942.95%
Cap/Sales 11.83%
Interest Coverage 36.02
Cash Conversion 21.97%
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 1.34
Altman-Z 2.03
F-Score4
WACC14.36%
ROIC/WACC0.59
Cap/Depr(3y)977.06%
Cap/Depr(5y)903.15%
Cap/Sales(3y)13.02%
Cap/Sales(5y)9.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.24%
EPS 3Y63.93%
EPS 5Y55.38%
EPS Q2Q%10.53%
EPS Next Y26.72%
EPS Next 2Y10.46%
EPS Next 3Y5.94%
EPS Next 5YN/A
Revenue 1Y (TTM)46.98%
Revenue growth 3Y52.71%
Revenue growth 5Y49.53%
Sales Q2Q%21%
Revenue Next Year38.03%
Revenue Next 2Y29.46%
Revenue Next 3Y23.48%
Revenue Next 5Y22.83%
EBIT growth 1Y46.21%
EBIT growth 3Y64.58%
EBIT growth 5Y71.29%
EBIT Next Year68.35%
EBIT Next 3Y24.61%
EBIT Next 5Y26.35%
FCF growth 1Y55.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y130.71%
OCF growth 3YN/A
OCF growth 5YN/A